PEDRO
PÉREZ SEGURA
Profesor asociado de Ciencias de la Salud
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (10)
2024
-
Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2
International Journal of Molecular Sciences, Vol. 25, Núm. 4
2023
-
Mapping Immune Correlates and Surfaceome Genes in BRAF Mutated Colorectal Cancers
Current Oncology, Vol. 30, Núm. 3, pp. 2569-2581
2022
-
Genomic mapping of copy number variations influencing immune response in breast cancer
Frontiers in Oncology, Vol. 12
2021
-
Major and durable response to second-line pembrolizumab-carboplatin-paclitaxel in an oral cavity cancer patient
Anti-Cancer Drugs, Vol. 32, Núm. 5, pp. 580-584
-
Safety and Efficacy of Cetuximab-Based Salvage Chemotherapy After Checkpoint Inhibitors in Head and Neck Cancer
Oncologist, Vol. 26, Núm. 6, pp. e1018-e1035
2020
2019
-
Durable intracranial and extracranial response to nivolumab with appearance of secondary resistance in a heavily pretreated patient with head and neck cancer
Head and Neck, Vol. 41, Núm. 6, pp. E86-E92
2018
2017
-
Phase II trial of dacomitinib, a pan-human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification
Neuro-Oncology, Vol. 19, Núm. 11, pp. 1522-1531
2015
-
Mammographic density and breast cancer in women from high risk families
Breast Cancer Research, Vol. 17, Núm. 1